Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03872700 · ClinicalTrials.gov registry record · Phase 3
Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage
A Phase 3 study of Abscess, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 49
- Enrollment target
- 1
- Study location
NCT03872700 is a Phase 3 study of Abscess that has completed, run by Montefiore Medical Center. The registered enrollment target is 49 participants, below the 386-participant average among 13 other Abscess trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03872700, a Phase 3 study of Abscess, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial aims to compare the analgesic efficacy of intranasal fentanyl to placebo as analgesic adjunct to conventional local anesthesia for the treatment of pain of the overall procedure in adult patients undergoing lidocaine infiltration and subsequent abscess incision and drainage in the Emergency Department (ED).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Intranasal fentanyl
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03872700
The ClinicalTrials.gov registry entry for NCT03872700 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 386-participant average among 13 other Abscess trials with a reported enrollment target (87% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03872700 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03872700 about?
NCT03872700 is a clinical study titled "Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage". This randomized clinical trial aims to compare the analgesic efficacy of intranasal fentanyl to placebo as analgesic adjunct to conventional local anesthesia for the treatment of pain of the overall procedure in adult patients undergoing lidocaine infiltration and subsequent abscess incision and dra...
What is the current status of trial NCT03872700?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 49 participants. The study started on 2019-08-01. Estimated completion is 2022-12-31.
What conditions does trial NCT03872700 study?
This clinical trial studies the following conditions: Abscess.
What interventions are being tested in trial NCT03872700?
The interventions under investigation include: Placebo (DRUG), Intranasal fentanyl (DRUG).
Who is sponsoring clinical trial NCT03872700?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03872700 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
COMPLETED · Phase 3
-
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
COMPLETED · Phase 3
-
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
COMPLETED · Phase 3
-
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
COMPLETED · Phase 3
-
Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses
COMPLETED · Phase 3
-
Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.